Colon Cancer: A Role for Cyclo-oxygenase-2-Specific Nonsteroidal Anti-Inflammatory Drugs

ISSN： 1170-229X

Source： Drugs & Aging, Vol.16, Iss.5, 2000-05, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Meloxicam: A Cyclo-Oxygenase-2 Preferential Nonsteroidal Anti-Inflammatory Drug

By Davies N.M.

Clinical Pharmacokinetics, Vol. 36, Iss. 2, 1999-02 ,pp. : 115-126

Adis International

Access to resources Recommend Favorite

Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer

Current Medicinal Chemistry, Vol. 22, Iss. 24, 2015-01 ,pp. : 2812-2818

Bentham Science Publishers

Access to resources Recommend Favorite

Non-steroidal anti-inflammatory drugs in cancer treatment

By Cuendet Muriel Pezzuto John M

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 827-835

Informa Healthcare

Access to resources Recommend Favorite

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells

By Kawai S. Nishida S. Kato M. Furumaya Y. Okamoto R. Koshino T. Mizushima Y.

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 87-94

Elsevier

Access to resources Recommend Favorite

Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1795-1804

Bentham Science Publishers

Access to resources Recommend Favorite